Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olga Vladimirovna Orlova
Observed names:
O V Orlova,
O. V. Orlova,
O.V. Orlova,
Olga V. Orlova,
О. В. Орлова
Institutions:
Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency,
Federal Medical-Biological Agency
Observed institutions:
Engelhardt Institute of Molecular Biology,
Russian Academy of Sciences,
Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency,
Federal Medical-Biological Agency
ORCID:
0000-0001-7882-8033
Observed ORCID:
0000-0001-7882-8033
OpenAlex ID:
A5075469264
New insights into the induction of the heat shock proteins in baculovirus infected insect cells
2011
·
Yulia V. Lyupina
, Olga G. Zatsepina
, et al.
·
Virology
·
50
PDF
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
2022
·
Olga Vladimirovna Orlova
, Dina Viktorovna Glazkova
, et al.
·
Vaccines
·
41
PDF
Proteotoxic stress induced by Autographa californica nucleopolyhedrovirus infection of Spodoptera frugiperda Sf9 cells
2012
·
Yulia V. Lyupina
, Svetlana B. Abaturova
, et al.
·
Virology
·
19
The Role of HCV E2 Protein Glycosylation in Functioning of Virus Envelope Proteins in Insect and Mammalian Cells
2015
·
O. V. Orlova
, V. L. Drutsa
, et al.
·
Acta Naturae
·
17
Essential function of VCP/p97 in infection cycle of the nucleopolyhedrovirus AcMNPV in Spodoptera frugiperda Sf9 cells
2018
·
Yulia V. Lyupina
, Pavel A. Erokhov
, et al.
·
Virus Research
·
12
Egress of budded virions of Autographa californica nucleopolyhedrovirus does not require activity of Spodoptera frugiperda HSP/HSC70 chaperones
2014
·
Yulia V. Lyupina
, Olga V. Orlova
, et al.
·
Virus Research
·
12
Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice
2022
·
Ramil R. Mintaev
, Dina V. Glazkova
, et al.
·
Vaccines
·
11
PDF
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
2023
·
Ramil R. Mintaev
, Dina V. Glazkova
, et al.
·
Vaccines
·
10
PDF
Hepatitis C virus structural proteins and virus-like particles produced in recombinant baculovirus-infected insect cells
2010
·
S. N. Belzhelarskaya
, N. N. Koroleva
, et al.
·
Molecular Biology
·
8
Proteomics of the 26S proteasome in Spodoptera frugiperda cells infected with the nucleopolyhedrovirus, AcMNPV
2016
·
Yulia V. Lyupina
, Olga G. Zatsepina
, et al.
·
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
·
7
[Characterization of hepatitis C virus structural proteins and HCV-like particles produced in recombinant baculovirus infected insect cells].
2010
·
S N Belzhelarskaia
, N N Koroleva
, et al.
·
PubMed
·
5
Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus
2020
·
O.V. Orlova
, D.V. Glazkova
, et al.
·
Journal of Virological Methods
·
4
Characterization of the 20S proteasome of the lepidopteran, Spodoptera frugiperda
2019
·
Oksana I. Kravchuk
, Yulia V. Lyupina
, et al.
·
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
·
3
Hepatitis C virus: The role of N-glycosylation sites of viral genotype 1b proteins for formation of viral particles in insect and mammalian cells
2016
·
S.N. Beljelarskaya
, O.V. Orlova
, et al.
·
Biochemistry and Biophysics Reports
·
3
PDF
Role of N-linked glycans of HCV glycoprotein E1 in folding of structural proteins and formation of viral particles
2013
·
O. V. Orlova
, V. L. Drutsa
, et al.
·
Molecular Biology
·
3
Study of the protective efficacy of CombiMab-2 against human immunodeficiency virus type 1 in mice humanised with CD4+ T-lymphocytes
2024
·
D. S. Leontyev
, F. A. Urusov
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
2
PDF
Comparative Evaluation of the Activity of Various Lentiviral Vectors Containing Three Anti-HIV Genes
2023
·
Olga Vladimirovna Orlova
, Dina Viktorovna Glazkova
, et al.
·
Microorganisms
·
2
PDF
Dynamics of Transgene Expression in the MVA Vaccine Vector under the Control of the p11, p13.5, pLEO160, p7.5, and mH5 Promoters and Independence of the Transgene Expression Level from the Insertion Locus
2025
·
O. V. Orlova
, D. V. Glazkova
, et al.
·
Molecular Biology
·
1
Роль N-гликанов гликопротеина Е1 вируса гепатита С в процессе сборки структурных белков вируса и формировании вирусных частиц
2013
·
О. В. Орлова
, В. Л. Друца
, et al.
·
Molecular Biology
·
1
[Dynamics of Transgene Expression in the MVA Vaccine Vector under the Control of the p11, p13.5, pLEO160, p7.5, and mH5 Promoters and Independence of the Transgene Expression Level from the Insertion Locus].
2025
·
O V Orlova
, D V Glazkova
, et al.
·
PubMed
An MVA-based vector expressing the SARS-CoV-2 RBD fused to N protein induces neutralizing antibodies and T-cell immune response in mice
2025
·
D. V. Glazkova
, R. R. Mintaev
, et al.
·
Bulletin of Experimental Biology and Medicine
Effect of the C12L, A35R, A40R, and A41L genes of MVA vector on the immunogenicity of recombinant MVA expressing the SARS-CoV-2 Spike protein
2025
·
O. V. Orlova
, D. V. Glazkova
, et al.
·
Bulletin of Experimental Biology and Medicine
Dynamics of transgene expression in the MVA vaccine vector under the control of the p11, p13.5, pLEO160, p7.5 and mH5 promoters, independence of the transgene expression level from the insertion locus
2025
·
O. V. Orlova
·
Molecular Biology
Development of the Technology Platform Based on the Modified Vaccinia Ankara for Rapid Production of Vector Vaccines
2024
·
R.R. Mintaev
, D.V. Glazkova
, et al.
·
Высшая школа: научные исследования
PDF
Роль гликозилирования белка Е2 вируса гепатита с в функционировании белков оболочки вируса в клетках насекомых и млекопитающих
2015
·
Olga V. Orlova
, В. Л. Друца
, et al.
·
Acta Naturae
Show more works
View as search
Works count:
26
Citation count:
220
H-index:
8
I10-index:
8
Year
Topic
Type